AIM ImmunoTech (AIM) Assets (QoQ) (2011 - 2026)
AIM ImmunoTech (AIM) Assets (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | AIM ImmunoTech | 4.45 Mn | -5.51 Mn | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.29% |
| Mar 31, 2026 | 48.48% |
| Dec 31, 2025 | 5.24% |
| Sep 30, 2025 | 33.06% |
| Jun 30, 2025 | -33.91% |
| Mar 31, 2025 | -27.42% |
| Dec 31, 2024 | -36.65% |
| Sep 30, 2024 | -13.53% |
| Jun 30, 2024 | -2.93% |
| Mar 31, 2024 | -16.47% |
| Dec 31, 2023 | -30.44% |
| Sep 30, 2023 | -17.12% |
| Jun 30, 2023 | -10.26% |
| Mar 31, 2023 | -7.47% |
| Dec 31, 2022 | -12.52% |
| Sep 30, 2022 | -9.04% |
| Jun 30, 2022 | -6.04% |
| Mar 31, 2022 | -6.14% |
| Dec 31, 2021 | -8.53% |
| Sep 30, 2021 | -5.46% |